Stock Chart

ZBH

$94.86 -1.19%
Score: 39.4 AVOID NEW MONEY
LEAPs: SELL $105
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $105
Premium: $8.07
Expiry: Sep 17, 2027
Target: $96
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.74x (vs SPY: 1.0x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 21, 2026
Falling Channel weak / forming — below our quality gate quality 50/100
A Falling Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ZBH - Zimmer Biomet Holdings, Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in …

Key Statistics

Market Cap $18B
P/E Ratio 23.30
Dividend Yield 0.01%

This ZBH stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ZBH's price movements with trendlines, gamma walls, and key support/resistance levels.